We are a Swiss biotech company, specializing in rapid, high-yield, and selective immuno-purification of extracellular vesicles (EVs).
Our mission is to revolutionize EV-based therapeutic and diagnostic applications with our cutting-edge technology. Our flagship product is a portable, versatile device that purifies EVs directly from raw biosamples in under 10 minutes, without requiring bulky or expensive equipment. This solution integrates seamlessly into diverse workflows, ensuring efficiency and convenience. In addition to our device, we offer custom purification services and supply high-quality EVs sourced from various biological materials.
We serve biopharmaceutical companies, university research labs, hospitals, veterinary clinics, and scientists in the field of biological nanoparticle research. By leveraging our advanced biopurification technology, we simplify the purification of nanometric entities, making it efficient, accessible, and transformative for researchers worldwide.
Company Details
- Employees
- 4
- Founded
- 2024
- Address
- Wagistrasse 18, Schlieren,zurich 8952,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://acytronix.ch/
- HQ
- Schlieren, Zurich
Acytronix Questions
Acytronix's website is https://acytronix.ch/
Acytronix's LinkedIn profile is https://ch.linkedin.com/company/acytronix
Acytronix has
4 employees.
View email and phone details for 4
employees at Acytronix.
Acytronix's industry is
Biotechnology Research
Acytronix's top competitors are
Endpoint Health,
Glycocalyx Therapeutics Ag,
Atlyphe Ag,
Innosuisse,
Transheps,
Eviive Ag,
Evis Bioscience Ag,
Apricot Bio,
Sydra,
Cellx Biosolutions.
Acytronix's categories are Biotechnology Research
Acytronix's founding year is 2024
